Five Prime Therapeutics Inc (FPRX) stock is up 533.44% over the last 12 months, and the average rating from Wall Street analysts is a Strong Buy. InvestorsObserver’s proprietary ranking system, gives FPRX stock a score of 80 out of a possible 100.
That rank is influenced by a short-term technical score of 100. FPRX's rank also includes a long-term technical score of 100. The fundamental score for FPRX is 39. In addition to the average rating from Wall Street analysts, FPRX stock has a mean target price of 24.714. This means analysts expect the stock to rise 21.92% over the next 12 months.
What's Happening with FPRX Stock Today
Five Prime Therapeutics Inc (FPRX) stock is down -2.69% while the S&P 500 is lower by -0.27% as of 3:12 PM on Tuesday, Nov 17. FPRX is lower by -$0.56 from the previous closing price of $20.83 on volume of 708,018 shares. Over the past year the S&P 500 is up 15.86% while FPRX is up 533.44%. FPRX lost -$2.68 per share in the over the last 12 months.
Click Here to get the full Stock Score Report on Five Prime Therapeutics Inc (FPRX) Stock.